The Company's Board of Directors on April 24, 2024 approved ...
The Company's Board of Directors on April 24, 2024 approved a reverse stock split of its Common Stock at a split ratio of between 1-for-2 and 1-for-16. Pending approval at the Company's annual shareholder meeting on June 17, 2024, the board expects to authorize a reverse stock split at a ratio within such range as soon as practicable after that date, with the intent to regain compliance with the Nasdaq's Minimum Bid Price Requirement. The Company may not regain compliance and may not be able to obtain a favorable final decision from the Panel.
Did you miss out on this? June Shareholders meeting they are considering another RS.
Did you miss out on this? June Shareholders meeting they are considering another RS.
NUTEX HEALTH ANNOUNCES NASDAQ DELISTING NOTIFICATION AND STAY PENDING ONGOING APPEAL. NO IMMEDIATE EFFECT ON THE LISTING OR TRADING OF THE COMMON STOCK.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
